Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up
Prostate Cancer and Prostatic Diseases, Published online: 13 December 2019; doi:10.1038/s41391-019-0198-2Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 13, 2019 Category: Urology & Nephrology Authors: Stefano Luzzago Michele Catellani Ettore Di Trapani Gabriele Cozzi Francesco A. Mistretta Roberto Bianchi Paola Pricolo Andrea Conti Eleonora Ancona Nicol ò Piacentini Sarah Alessi Giuseppe Renne Matteo Ferro Deliu-Victor Matei Gennaro Musi Barbara Alicj Source Type: research

Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study
Prostate Cancer and Prostatic Diseases, Published online: 11 December 2019; doi:10.1038/s41391-019-0196-4Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 11, 2019 Category: Urology & Nephrology Authors: Claudio Maurizio Pacella Gianluigi Patelli Gennaro Iapicca Guglielmo Manenti Tommaso Perretta Colleen P. Ryan Renato Esposito Giovanni Mauri Source Type: research

Prostate Cancer and Prostatic Diseases Best of Asia, 2019: challenges and opportunities
Prostate Cancer and Prostatic Diseases, Published online: 06 December 2019; doi:10.1038/s41391-019-0193-7Prostate Cancer and Prostatic Diseases Best of Asia, 2019: challenges and opportunities (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 6, 2019 Category: Urology & Nephrology Authors: Yao Zhu Stephen J. Freedland Dingwei Ye Source Type: research

Risk of dementia following androgen deprivation therapy for treatment of prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 29 November 2019; doi:10.1038/s41391-019-0189-3Risk of dementia following androgen deprivation therapy for treatment of prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 29, 2019 Category: Urology & Nephrology Authors: Anna Krasnova Matthew Epstein Maya Marchese Barbra A. Dickerman Alexander P. Cole Stuart R. Lipsitz Paul L. Nguyen Adam S. Kibel Toni K. Choueiri Shehzad Basaria Lorelei A. Mucci Maxine Sun Quoc-Dien Trinh Source Type: research

Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml
Prostate Cancer and Prostatic Diseases, Published online: 28 November 2019; doi:10.1038/s41391-019-0194-6Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 28, 2019 Category: Urology & Nephrology Authors: Ewa Witkowska-Patena Agnieszka Gi żewska Miros ław Dziuk Jolanta Mi śko Anna Budzy ńska Agata Wal ęcka-Mazur Source Type: research

Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysis
Prostate Cancer and Prostatic Diseases, Published online: 28 November 2019; doi:10.1038/s41391-019-0191-9Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 28, 2019 Category: Urology & Nephrology Authors: Timothy D. Malouff William C. Stross Danushka S. Seneviratne Mark R. Waddle Byron C. May Steven J. Buskirk Katherine S. Tzou Source Type: research

Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT
Prostate Cancer and Prostatic Diseases, Published online: 27 November 2019; doi:10.1038/s41391-019-0181-yGermline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 27, 2019 Category: Urology & Nephrology Authors: Mahbubl Ahmed Chee Goh Edward Saunders Clara Cieza-Borrella Zsofia Kote-Jarai Fredrick R. Schumacher Ros Eeles Source Type: research

How can mpMRI help surgical planning in high risk prostate cancer?
Prostate Cancer and Prostatic Diseases, Published online: 25 November 2019; doi:10.1038/s41391-019-0192-8How can mpMRI help surgical planning in high risk prostate cancer? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 25, 2019 Category: Urology & Nephrology Authors: Lorenzo Bianchi Riccardo Schiavina Eugenio Brunocilla Source Type: research

A polymeric paste-drug formulation for intratumoral treatment of prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 25 November 2019; doi:10.1038/s41391-019-0190-xA polymeric paste-drug formulation for intratumoral treatment of prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 25, 2019 Category: Urology & Nephrology Authors: Claudia Kesch Veronika Schmitt Samir Bidnur Marisa Thi Eliana Beraldi Igor Moskalev Virginia Yago Mary Bowden Hans Adomat Ladan Fazil John K. Jackson Martin E. Gleave Source Type: research

Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia
Prostate Cancer and Prostatic Diseases, Published online: 19 November 2019; doi:10.1038/s41391-019-0186-6Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 19, 2019 Category: Urology & Nephrology Authors: Judith Stangl-Kremser Rodrigo Suarez ‐Ibarrola David D ’ Andrea Stephan M. Korn Mario Pones Gero Kramer Maximilian Marhold Michael Krainer Dmitry V. Enikeev Petr V. Glybochko Dietmar Tamandl Shahrokh F. Shariat Pascal Baltzer Source Type: research

Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 19 November 2019; doi:10.1038/s41391-019-0188-4Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 19, 2019 Category: Urology & Nephrology Authors: William S. Chen Eric L. Feng Rahul Aggarwal Adam Foye Tomasz M. Beer Joshi J. Alumkal Martin Gleave Kim N. Chi Robert E. Reiter Matthew B. Rettig Christopher P. Evans Eric J. Small Nima Sharifi Shuang G. Zhao Source Type: research

Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia
Prostate Cancer and Prostatic Diseases, Published online: 18 November 2019; doi:10.1038/s41391-019-0187-5Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 18, 2019 Category: Urology & Nephrology Authors: Kevin T. McVary Bradley Holland J. Randolf Beahrs Source Type: research

Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
Prostate Cancer and Prostatic Diseases, Published online: 12 November 2019; doi:10.1038/s41391-019-0185-7Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 12, 2019 Category: Urology & Nephrology Authors: Joseph Marascio Daniel E. Spratt Jingbin Zhang Edouard J. Trabulsi Tiffany Le Worlanyo Sosu Sedzorme Whitney H. Beeler Elai Davicioni Bashar Dabbas Daniel W. Lin John L. Gore Matthew Bloom Mark Mann J. Ryan Mark Anne Calvaresi James L. Godwin Peter McCue Source Type: research

Feasibility and continence outcomes of extended prostatic urethral preservation during robot-assisted radical prostatectomy
Prostate Cancer and Prostatic Diseases, Published online: 07 November 2019; doi:10.1038/s41391-019-0173-yFeasibility and continence outcomes of extended prostatic urethral preservation during robot-assisted radical prostatectomy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 7, 2019 Category: Urology & Nephrology Authors: Luciano A. Nunez Bragayrac Ahmed A. Hussein Kristopher Attwood Elena Pop Gaybrielle James Jennifer Osei Christine Murekeysoni Eric C. Kauffman Source Type: research

Prostate cancer characteristics and cancer-specific mortality of Native American patients
Prostate Cancer and Prostatic Diseases, Published online: 06 November 2019; doi:10.1038/s41391-019-0184-8Prostate cancer characteristics and cancer-specific mortality of Native American patients (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 6, 2019 Category: Urology & Nephrology Authors: Marina Deuker Sophie Knipper Angela Pecoraro Carlotta Palumbo Giuseppe Rosiello Stefano Luzzago Zhe Tian Fred Saad Felix Chun Pierre I. Karakiewicz Source Type: research

Hyperpolarized 13C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study
Prostate Cancer and Prostatic Diseases, Published online: 04 November 2019; doi:10.1038/s41391-019-0180-zHyperpolarized 13C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 4, 2019 Category: Urology & Nephrology Authors: Hsin-Yu Chen Rahul Aggarwal Robert A. Bok Michael A. Ohliger Zi Zhu Philip Lee Jeremy W. Gordon Mark van Criekinge Lucas Carvajal James B. Slater Peder E. Z. Larson Eric J. Small John Kurhanewicz Daniel B. Vigneron Source Type: research

Adverse events related to abiraterone and enzalutamide treatment: analysis of the EudraVigilance database and meta-analysis of registrational phase III studies
Prostate Cancer and Prostatic Diseases, Published online: 04 November 2019; doi:10.1038/s41391-019-0182-xAdverse events related to abiraterone and enzalutamide treatment: analysis of the EudraVigilance database and meta-analysis of registrational phase III studies (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 4, 2019 Category: Urology & Nephrology Authors: Cosimo De Nunzio Riccardo Lombardo Giorgia Tema Olivia Voglino Angela Sica Valeria Baldassarri Antonio Nacchia Roberto Iacovelli Sergio Bracarda Andrea Tubaro Source Type: research

Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies
Prostate Cancer and Prostatic Diseases, Published online: 04 November 2019; doi:10.1038/s41391-019-0183-9Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 4, 2019 Category: Urology & Nephrology Authors: Elio Mazzone Francesco A. Mistretta Sophie Knipper Zhe Tian Carlotta Palumbo Giorgio Gandaglia Nicola Fossati Shahrokh F. Shariat Fred Saad Francesco Montorsi Markus Graefen Alberto Briganti Pierre I. Karakiewicz Source Type: research

Tobacco smoking and death from prostate cancer in US veterans
Prostate Cancer and Prostatic Diseases, Published online: 17 October 2019; doi:10.1038/s41391-019-0178-6Tobacco smoking and death from prostate cancer in US veterans (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 17, 2019 Category: Urology & Nephrology Authors: Paul Riviere Abhishek Kumar Elaine Luterstein Lucas K. Vitzthum Vinit Nalawade Reith R. Sarkar Alex K. Bryant John P. Einck Arno J. Mundt James D. Murphy Brent S. Rose Source Type: research

Exposure–response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 14 October 2019; doi:10.1038/s41391-019-0179-5Exposure–response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 14, 2019 Category: Urology & Nephrology Authors: M. van Nuland S. L. Groenland A. M. Bergman N. Steeghs H. Rosing N. Venekamp A. D. R. Huitema J. H. Beijnen Source Type: research

A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 14 October 2019; doi:10.1038/s41391-019-0176-8A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 14, 2019 Category: Urology & Nephrology Authors: Ashley E. Ross Paula J. Hurley Phuoc T. Tran Steven P. Rowe Benjamin Benzon Tanya O ’ Neal Carolyn Chapman Rana Harb Yelena Milman Bruce J. Trock Charles G. Drake Emmanuel S. Antonarakis Source Type: research

Lutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies
Prostate Cancer and Prostatic Diseases, Published online: 08 October 2019; doi:10.1038/s41391-019-0174-xLutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 8, 2019 Category: Urology & Nephrology Authors: Amir Iravani John Violet Arun Azad Michael S. Hofman Source Type: research

The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 07 October 2019; doi:10.1038/s41391-019-0177-7The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 7, 2019 Category: Urology & Nephrology Authors: Yuqiu Ge Qianqian Shi Wenxi Yao Yang Cheng Gaoxiang Ma Source Type: research

United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015
Prostate Cancer and Prostatic Diseases, Published online: 07 October 2019; doi:10.1038/s41391-019-0175-9United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015 (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 7, 2019 Category: Urology & Nephrology Authors: Santino S. Butler Stacy Loeb Alexander P. Cole Cierra Zaslowe-Dude Vinayak Muralidhar Daniel W. Kim Edward M. Schaeffer Quoc-Dien Trinh Paul L. Nguyen Brandon A. Mahal Source Type: research

Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 09 September 2019; doi:10.1038/s41391-019-0171-0Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 9, 2019 Category: Urology & Nephrology Authors: Janet Baack Kukreja Tharakeswara K. Bathala Chad A. Reichard Patricia Troncoso Scott Delacroix Benjamin Davies Scott Eggener Marc Smaldone Mohummad Minhaj Siddiqui Matthew Tollefson Brian F. Chapin Source Type: research

Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC
Prostate Cancer and Prostatic Diseases, Published online: 30 August 2019; doi:10.1038/s41391-019-0172-zTherapeutic potential of ReACp53 targeting mutant p53 protein in CRPC (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 30, 2019 Category: Urology & Nephrology Authors: Yaqun Zhang Lingfan Xu Yan Chang YanJing Li William Butler Er Jin Aifen Wang Yulei Tao Xufeng Chen Chaozhao Liang Jiaoti Huang Source Type: research

Regular vs. selective use of closed suction drains following robot-assisted radical prostatectomy: results from a regional quality improvement collaborative
Prostate Cancer and Prostatic Diseases, Published online: 29 August 2019; doi:10.1038/s41391-019-0170-1Regular vs. selective use of closed suction drains following robot-assisted radical prostatectomy: results from a regional quality improvement collaborative (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 29, 2019 Category: Urology & Nephrology Authors: Samer W. Kirmiz Stephen Babitz Susan Linsell Ji Qi Christopher M. Brede David C. Miller James E. Montie Brian R. Lane Source Type: research

The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study
Prostate Cancer and Prostatic Diseases, Published online: 28 August 2019; doi:10.1038/s41391-019-0169-7The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 28, 2019 Category: Urology & Nephrology Authors: Jasmir G. Nayak Nicholas Scalzo Alice Chu Benjamin Shiff James T. Kearns Geolani W. Dy Liam C. Macleod Matthew Mossanen William J. Ellis Daniel W. Lin Jonathan L. Wright Lawrence D. True John L. Gore Source Type: research

Second Reply to Letter to the Editor re: “Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting”
Prostate Cancer and Prostatic Diseases, Published online: 28 August 2019; doi:10.1038/s41391-019-0166-xSecond Reply to Letter to the Editor re: “Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting” (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 28, 2019 Category: Urology & Nephrology Authors: Jay White Ronald F. Tutrone Mark A. Reynolds Source Type: research

Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance
Prostate Cancer and Prostatic Diseases, Published online: 27 August 2019; doi:10.1038/s41391-019-0167-9Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 27, 2019 Category: Urology & Nephrology Authors: Annika Herlemann Huei-Chung Huang Ridwan Alam Jeffery J. Tosoian Hyung L. Kim Eric A. Klein Jeffry P. Simko June M. Chan Brian R. Lane John W. Davis Elai Davicioni Felix Y. Feng Peter McCue Hyun Kim Robert B. Den Tarek A. Bismar Peter R. Carroll Matthew R Source Type: research

Effect of dietary omega-3 fatty acids on castrate-resistant prostate cancer and tumor-associated macrophages
Prostate Cancer and Prostatic Diseases, Published online: 22 August 2019; doi:10.1038/s41391-019-0168-8Effect of dietary omega-3 fatty acids on castrate-resistant prostate cancer and tumor-associated macrophages (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 22, 2019 Category: Urology & Nephrology Authors: Pei Liang Susanne M. Henning Johnny Guan Tristan Grogan David Elashoff Pinchas Cohen William J. Aronson Source Type: research

Inherited risk assessment of prostate cancer: it takes three to do it right
Prostate Cancer and Prostatic Diseases, Published online: 15 August 2019; doi:10.1038/s41391-019-0165-yInherited risk assessment of prostate cancer: it takes three to do it right (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 15, 2019 Category: Urology & Nephrology Authors: Jianfeng Xu Craig V. Labbate William B. Isaacs Brian T. Helfand Source Type: research

Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy
Prostate Cancer and Prostatic Diseases, Published online: 05 August 2019; doi:10.1038/s41391-019-0164-zPreoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 5, 2019 Category: Urology & Nephrology Authors: Cong Huang Gang Song Huihui Wang Zhiyong Lin He Wang Guangjie Ji Shouyi Zhang Yuanshan Guo Jie Li Zhengqing Bao Peng Hong Yicong Du Peng Li Qun He Shiming He Yanqing Gong Xiaoying Wang Liqun Zhou Source Type: research

The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy
Prostate Cancer and Prostatic Diseases, Published online: 30 July 2019; doi:10.1038/s41391-019-0163-0The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 30, 2019 Category: Urology & Nephrology Authors: Sheliyan Raveenthiran John Yaxley Troy Gianduzzo Boon Kua Louise McEwan David Wong Gail Tsang James MacKean Source Type: research

Correction to: Role of the DNA damage response in prostate cancer formation, progression and treatment
Prostate Cancer and Prostatic Diseases, Published online: 17 July 2019; doi:10.1038/s41391-019-0162-1Correction to: Role of the DNA damage response in prostate cancer formation, progression and treatment (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 17, 2019 Category: Urology & Nephrology Authors: Wenhao Zhang Dik C. van Gent Luca Incrocci Wytske M. van Weerden Julie Nonnekens Source Type: research

Cost-effectiveness analysis of Abiraterone Acetate versus Docetaxel in the management of metastatic castration-sensitive prostate cancer: Hong Kong’s perspective
Prostate Cancer and Prostatic Diseases, Published online: 04 July 2019; doi:10.1038/s41391-019-0161-2Cost-effectiveness analysis of Abiraterone Acetate versus Docetaxel in the management of metastatic castration-sensitive prostate cancer: Hong Kong’s perspective (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - July 4, 2019 Category: Urology & Nephrology Authors: Chi Leung Chiang Tsz Him So Tai Chung Lam Horace C. W. Choi Source Type: research

Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up
Prostate Cancer and Prostatic Diseases, Published online: 27 June 2019; doi:10.1038/s41391-019-0160-3Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 27, 2019 Category: Urology & Nephrology Authors: Stefano Luzzago Michele Catellani Ettore Di Trapani Gabriele Cozzi Francesco A. Mistretta Roberto Bianchi Paola Pricolo Andrea Conti Eleonora Ancona Nicol ò Piacentini Sarah Alessi Giuseppe Renne Matteo Ferro Deliu-Victor Matei Gennaro Musi Barbara Alicj Source Type: research

Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy
Prostate Cancer and Prostatic Diseases, Published online: 27 June 2019; doi:10.1038/s41391-019-0159-9Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 27, 2019 Category: Urology & Nephrology Authors: Daniel J. Canter Stephen Freedland Saradha Rajamani Maria Latsis Margaret Variano Shams Halat Jonathan Tward Todd Cohen Steven Stone Thorsten Schlomm Jay Bishoff Stephen Bardot Source Type: research

Financial implications of biparametric prostate MRI
Prostate Cancer and Prostatic Diseases, Published online: 25 June 2019; doi:10.1038/s41391-019-0158-xFinancial implications of biparametric prostate MRI (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 25, 2019 Category: Urology & Nephrology Authors: Kristin K. Porter Alex King Samuel J. Galgano Rachael L. Sherrer Jennifer B. Gordetsky Soroush Rais-Bahrami Source Type: research

Contemporary national trends in prostate cancer risk profile at diagnosis
Prostate Cancer and Prostatic Diseases, Published online: 24 June 2019; doi:10.1038/s41391-019-0157-yContemporary national trends in prostate cancer risk profile at diagnosis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 24, 2019 Category: Urology & Nephrology Authors: Sean A. Fletcher Nicolas von Landenberg Alexander P. Cole Philipp Gild Toni K. Choueiri Stuart R. Lipsitz Quoc-Dien Trinh Adam S. Kibel Source Type: research

Role of the DNA damage response in prostate cancer formation, progression and treatment
Prostate Cancer and Prostatic Diseases, Published online: 13 June 2019; doi:10.1038/s41391-019-0153-2Role of the DNA damage response in prostate cancer formation, progression and treatment (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 13, 2019 Category: Urology & Nephrology Authors: Wenhao Zhang Dik C. van Gent Luca Incrocci Wytske M. van Weerden Julie Nonnekens Source Type: research

Efficacy and safety of periprostatic nerve block combined with perineal subcutaneous anaesthesia and intrarectal lidocaine gel in transrectal ultrasound guided transperineal prostate biopsy: A Prospective Randomised Controlled Trial
Prostate Cancer and Prostatic Diseases, Published online: 03 June 2019; doi:10.1038/s41391-019-0155-0Efficacy and safety of periprostatic nerve block combined with perineal subcutaneous anaesthesia and intrarectal lidocaine gel in transrectal ultrasound guided transperineal prostate biopsy: A Prospective Randomised Controlled Trial (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 3, 2019 Category: Urology & Nephrology Authors: Zhengtong Lv Huichuan Jiang Xiheng Hu Changzhao Yang Harripersaud Chand Congyi Tang Yuan Li Source Type: research

Appetite-regulating hormones—leptin, adiponectin and ghrelin—and the development of prostate cancer: a systematic review and exploratory meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 30 May 2019; doi:10.1038/s41391-019-0154-1Appetite-regulating hormones—leptin, adiponectin and ghrelin—and the development of prostate cancer: a systematic review and exploratory meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 30, 2019 Category: Urology & Nephrology Authors: Charlotte Zoe Angel Isabel Iguacel Amy Mullee Neela Guha Rachel Wasson Declan J. McKenna Marc J. Gunter Vitaly Smelov Inge Huybrechts Source Type: research

Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 30 May 2019; doi:10.1038/s41391-019-0156-zPerformance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 30, 2019 Category: Urology & Nephrology Authors: Shoji Kimura Mohammad Abufaraj Florian Janisch Takehiro Iwata Mehdi Kardoust Parizi Beat Foerster Nicola Fossati Alberto Briganti Shin Egawa Markus Hartenbach Shahrokh F. Shariat Source Type: research

Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)
Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC), Published online: 03 May 2019; doi:10.1038/s41391-019-0152-3Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC) (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 3, 2019 Category: Urology & Nephrology Authors: Charles J. Ryan Sandipan Dutta William K. Kelly Carly Russell Eric J. Small Michael J. Morris Mary-Ellen Taplin Susan Halabi Source Type: research

Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer
Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer, Published online: 01 May 2019; doi:10.1038/s41391-019-0145-2Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 1, 2019 Category: Urology & Nephrology Authors: Melanie A. Krook Hannah Barker Hui-Zi Chen Julie W. Reeser Michele R. Wing Dorrelyn Martin Amy M. Smith Thuy Dao Russell Bonneville Eric Samorodnitsky Jharna Miya Aharon G. Freud J. Paul Monk Steven K. Clinton Sameek Roychowdhury Source Type: research

Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials
Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials, Published online: 29 April 2019; doi:10.1038/s41391-019-0151-4Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 29, 2019 Category: Urology & Nephrology Authors: Jose Mauricio Mota Andrew J. Armstrong Steven M. Larson Josef J. Fox Michael J. Morris Source Type: research

Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer
Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer, Published online: 29 April 2019; doi:10.1038/s41391-019-0146-1Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 29, 2019 Category: Urology & Nephrology Authors: Drew Moghanaki Lauren E. Howard Amanda De Hoedt William J. Aronson Christopher J. Kane Christopher L. Amling Matthew R. Cooperberg Martha K. Terris Stephen J. Freedland Source Type: research

Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancer
Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancer, Published online: 17 April 2019; doi:10.1038/s41391-019-0147-0Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 17, 2019 Category: Urology & Nephrology Authors: Yaw A. Nyame Lamont Wilkins Daniel J. Greene Vishnu Ganesan Charles Dai Nima Almassi Andrew J. Stephenson Michael Gong Ryan Berglund Eric A. Klein Source Type: research

A predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsies
A predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsiesA predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsies, Published online: 15 April 2019; doi:10.1038/s41391-019-0149-yA predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsies (Source: Prostate Canc...
Source: Prostate Cancer and Prostatic Diseases - April 15, 2019 Category: Urology & Nephrology Authors: Lars Boesen Frederik B. Thomsen Nis N ørgaard Vibeke L øgager Ingegerd Balslev Rasmus Bisbjerg Henrik S. Thomsen Henrik Jakobsen Source Type: research